153 Results

People

  1. Bodei
    Bodei
  2. Motzer
    Motzer
  3. Hudis
    Hudis
  4. Mao
    Mao
  5. Mulhall
    Mulhall
  6. Riely
    Riely
  7. Scher
    Scher
  8. Wolchok
    Wolchok
  9. Zhang
    Zhang
  10. Coit
    Coit

Groups

  1. Department of Medicine (85)
  2. Solid Tumor Oncology Division (61)
  3. Surgery (30)
  4. Sloan Kettering Institute Postdocs (24)
  5. GSK Faculty (22)
  6. Survivorship Research (22)
  7. Hematologic Malignancies, Division of (18)
  8. Center for Hematologic Malignancies (15)
  9. Population Sciences Research Program (15)
  10. Radiology, Department of (15)
  1. "efficacy"
Formats
  1. Journal Article (128)
  2. Review (12)
  3. Meeting Abstract (6)
  4. Editorial (2)
  5. Guidelines (2)
  6. Book Section (1)
  7. Conference Paper (1)
  8. Correspondence (1)
Groups
  1. Department of Medicine (85)
  2. Solid Tumor Oncology Division (61)
  3. Surgery (30)
  4. Sloan Kettering Institute Postdocs (24)
  5. GSK Faculty (22)
  6. Survivorship Research (22)

More Groups

People
  1. Lisa Bodei (6)
  2. Robert Motzer (6)
  3. Clifford Hudis (5)
  4. Gregory Riely (5)
  5. Jedd Wolchok (5)
  6. John Mulhall (5)

More People

Years
  1. 2025 (8)
  2. 2024 (10)
  3. 2023 (9)
  4. 2022 (11)
  5. 2021 (15)
  6. 2020 (10)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Lancet Oncology (5)
  3. Cancer (4)
  4. Clinical Cancer Research (4)
  5. Annals of Oncology (3)
  6. Cancer Discovery (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (25)
  2. Elsevier Inc. (24)
  3. Elsevier Science, Inc. (12)
  4. Wiley Blackwell (10)
  5. American Association for Cancer Research (8)
  6. Springer (8)

More Publishers

Results (153)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated interim efficacy analysis and long-term safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients without prior chemotherapy (COU-AA-302)
    Journal Article

    Rathkopf, D. E.; Smith, M. R.; de Bono, J. S.; Logothetis, C. J.; Shore, N. D.; De Souza, P.; Fizazi, K.; Mulders, P. F. A.; Mainwaring, P.; Hainsworth, J. D.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • Cellular intrinsic factors involved in the resistance of squamous cell carcinoma to photodynamic therapy
    Journal Article

    Gilaberte, Y.; Milla, L.; Salazar, N.; Vera-Alvarez, J.; Kourani, O.; Damian, A.; Rivarola, V.; Roca, M. J.; Espada, J.; Gonzalez, S.; more...
    Journal of Investigative Dermatology (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Consistent therapeutic efficacy of CH5424802/RO5424802 in brain metastases among crizotinib-refractory ALK-positive non-small cell lung cancer (NSCLC) patients in an ongoing phase I/II study (AF-002JG/NP28761, NCT01588028)
    Meeting Abstract

    Ou, S. H. I.; Gadgeel, S.; Chiappori, A. A.; Gandhi, L.; Azada, M.; Garcia, L.; Takaya, I.; Yokoyama, S.; Kamei, T.; Tanaka, T.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Ki 67 is an independent predictive biomarker of cancer specific and local recurrence-free survival after lung tumor ablation
    Journal Article

    Sofocleous, C. T.; Garg, S. K.; Cohen, P.; Petre, E. N.; Gonen, M.; Erinjeri, J. P.; Downey, R. J.; Travis, W. D.; Solomon, S. B.
    Annals of Surgical Oncology (2013)

    Fulltext@MSK | Save
  • Long-term cardiac safety and outcomes of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab with and without lapatinib in patients with early breast cancer
    Journal Article

    Morris, P. G.; Iyengar, N. M.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Oeffinger, K. C.; Lin, N.; Moy, B.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials
    Journal Article

    Wolchok, J. D.; Weber, J. S.; Maio, M.; Neyns, B.; Harmankaya, K.; Chin, K.; Cykowski, L.; de Pril, V.; Humphrey, R.; Lebbé, C.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Dynamic tumor modeling of the dose-response relationship for everolimus in metastatic renal cell carcinoma using data from the phase 3 RECORD-1 trial
    Journal Article

    Stein, A.; Wang, W.; Carter, A. A.; Chiparus, O.; Hollaender, N.; Kim, H.; Motzer, R. J.; Sarr, C.
    BMC Cancer (2012)

    Fulltext@MSK | Save
  • Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: A subgroup efficacy analysis from the PROPEL study
    Journal Article

    Foss, F.; Horwitz, S. M.; Coiffier, B.; Bartlett, N.; Popplewell, L.; Pro, B.; Pinter-Brown, L. C.; Shustov, A.; Furman, R. R.; Haioun, C.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2012)

    Fulltext@MSK | Save
  • Opioid pharmacotherapy for chronic non-cancer pain in the United States: A research guideline for developing an evidence-base
    Journal Article

    Chapman, C. R.; Lipschitz, D. L.; Angst, M. S.; Chou, R.; Denisco, R. C.; Donaldson, G. W.; Fine, P. G.; Foley, K. M.; Gallagher, R. M.; Gilson, A. M.; more...
    Journal of Pain (2010)

    Fulltext@MSK | Save